Phenotype Summary

Phenotypes

Publication	Data		Phenotype
Monroe et al., 2022	Fig. 1		liver hepatocellular carcinoma increased amount, abnormal
	Fig. 2		liver lipid droplet formation increased frequency, abnormal
	Fig. 3		liver lipid biosynthetic process increased occurrence, abnormal liver phosphatidylserine biosynthetic process increased occurrence, abnormal
	Fig. 4		liver lipid biosynthetic process increased occurrence, abnormal
	Fig. 5		liver fatty acid beta-oxidation decreased process quality, abnormal liver hepatocellular carcinoma acox3 expression increased amount, abnormal liver hepatocellular carcinoma cebpa expression increased amount, abnormal liver hepatocellular carcinoma cpt1aa expression increased amount, abnormal liver hepatocellular carcinoma dgat2 expression decreased amount, abnormal liver hepatocellular carcinoma fasn expression increased amount, abnormal liver hepatocellular carcinoma pparg expression increased amount, abnormal liver hepatocellular carcinoma srebf1 expression decreased amount, abnormal liver lipid biosynthetic process decreased process quality, abnormal